Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations

Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations


An Abercrombie & Fitch store in San Francisco.

Getty Images

Shares of Abercrombie & Fitch soared in premarket trading, after the retailer crushed Wall Street’s earnings and sales expectations for the quarter and raised its forecast for the year.

Here’s how the retailer did in the fiscal second quarter ended July 29 compared with what Wall Street expected, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.10 vs. 17 cents expected
  • Revenue: $935.3 million vs $842.4 million expected

Net income for the three-month period rose to $56.9 million, or $1.10 per share, from a loss of $16.8 million, or 33 cents a share, in the year-ago period.

Net sales rose from $805.1 million in the year prior.

Abercrombie said it now anticipates net sales will rise by about 10% for the full fiscal year, up from $3.7 billion in the prior year. It had previously expected growth of between 2% and 4%.

It said it expects operating margins to improve, too, as costs of freight and raw materials fall. It anticipates operating margins to be in the range of 8% to 9%, compared with prior expectations of 5% to 6%.

The retailer’s sales and its stock price have shot up, as Abercrombie has reinvented its image from a mall store known for shirtless models and a strong scent of cologne to a retailer that resonates with a broader audience.

As of Tuesday’s close, shares of Abercrombie had shot up about 80% this year, far outpacing the approximately 14% gains of the S&P 500. Shares of the company touched a 52-week high of $43.47 earlier this week.

Abercrombie also has stood out because it’s defied industry-wide trends. Retailers including Home Depot, Target and Walmart have all spoken about consumers who aren’t spending as freely on discretionary items, such as clothing. Foot Locker echoed similar sentiments, as its sales plummeted and it cut full-year guidance on Wednesday.

This is a developing story. Please check back for updates.



Source

The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
Business

The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know

U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]

Read More
Estée Lauder expects 0 million tariff hit to full-year profitability; stock sinks more than 20%
Business

Estée Lauder expects $100 million tariff hit to full-year profitability; stock sinks more than 20%

In this photo illustration the Estee Lauder Companies Inc. logo seen displayed on a smartphone with Estee Lauder Companies Inc. logo in the background.  Thiago Prudencio | Lightrocket | Getty Images Estée Lauder said Thursday it’s expecting a $100 million hit to its full-year profitability because of tariff impacts. The beauty company’s stock tumbled more […]

Read More
Cheaper tequila and canned cocktails were the only bright spots for booze during a rough 2025
Business

Cheaper tequila and canned cocktails were the only bright spots for booze during a rough 2025

Various cans of alcoholic ready-to-drink beverages including Captain Morgan Rum and Coke, Bacardi MoJito, Archers and Lemonade, Malibu and Pineapple, Pina Colada Cocktail and Gordon’s Gin and Tonic are displayed for sale in a supermarket on January 10, 2024. John Keeble | Getty Images The U.S. alcohol industry had another sobering year in 2025. Spirits […]

Read More